Dr. Burak Zeybek, MD

Dr. Zeybek practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Zeybek's NPI, 1467869024, was assigned on July 16, 2014. Dr. Zeybek graduated from Istanbul University Fom in 2005. Dr. Zeybek holds Florida license ME156033.

Dr. Zeybek's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Zeybek's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zeybek practices. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Zeybek's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Zeybek is board certified in critical care medicine by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Zeybek's licenses on file in 3 states: Florida, Texas and Connecticut.

Dmand AI lists hysterectomy and ovarian cyst among the conditions Dr. Zeybek treats.

CMS data shows 531 Medicare services from Dr. Zeybek across 9 procedure codes in 2024, for 141 Medicare patients. Medicare paid $46,290 for them.

CMS counts 141 Medicare patients who saw Dr. Zeybek in 2024. The largest group is 65 to 74, with 64 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zeybek's median patient age at 71, with 96% women.

In 2024, Dr. Zeybek wrote 50 Medicare Part D claims for 23 patients. 76% of them were for generic drugs. CMS names the drug for 23 of them, across 2 drugs with 11 or more claims each, at $779 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Zeybek for performance year 2024, reported through an alternative payment model (APM). Dr. Zeybek accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 73 papers to Dr. Zeybek, published from 2012 to 2021. 2020 was the busiest year, with 11. The most frequent topics are Cell Line, Tumor, Hysterectomy and Uterine Cervical Neoplasms. Dr. Zeybek has published most often in J Minim Invasive Gynecol. Dr. Zeybek's most frequent co-authors are Alessandro D. Santin, MD, Masoud Azodi, MD and Elena S. Ratner, MD.

CMS Open Payments shows 8 general payments to Dr. Zeybek from 4 drug and device companies from 2018 to 2023. Food and beverage make up the largest share, 100% of the total. TESARO, Inc. paid the most, $141.

Dr. Zeybek graduated from Istanbul University Fom in 2005.

Dr. Zeybek is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.